318 related articles for article (PubMed ID: 29727806)
21. Cancer burden in the HIV-infected population in the United States.
Shiels MS; Pfeiffer RM; Gail MH; Hall HI; Li J; Chaturvedi AK; Bhatia K; Uldrick TS; Yarchoan R; Goedert JJ; Engels EA
J Natl Cancer Inst; 2011 May; 103(9):753-62. PubMed ID: 21483021
[TBL] [Abstract][Full Text] [Related]
22. [Causes of death among 91 HIV-infected adults in the era of potent antiretroviral therapy].
Sodqi M; Marih L; Lahsen AO; Bensghir R; Chakib A; Himmich H; El Filali KM
Presse Med; 2012 Jul; 41(7-8):e386-90. PubMed ID: 22350063
[TBL] [Abstract][Full Text] [Related]
23. Trends in cancer risk among people with AIDS in the United States 1980-2002.
Engels EA; Pfeiffer RM; Goedert JJ; Virgo P; McNeel TS; Scoppa SM; Biggar RJ;
AIDS; 2006 Aug; 20(12):1645-54. PubMed ID: 16868446
[TBL] [Abstract][Full Text] [Related]
24. AIDS related neoplasms in Genoa, Italy.
Gabutti G; Vercelli M; De Rosa MG; Orengo MA; Casella C; Garrone E; Orlandini C; Piersantelli N; Torresin A; Rizzo F
Eur J Epidemiol; 1995 Dec; 11(6):609-14. PubMed ID: 8861842
[TBL] [Abstract][Full Text] [Related]
25. Size of the Adult HIV-Infected Population Adjusted for the Unreported AIDS Mortality in the Santa Catarina State, Brazil, 2008-2017.
Tombini LHT; Kupek E
Curr HIV Res; 2019; 17(4):277-289. PubMed ID: 31556859
[TBL] [Abstract][Full Text] [Related]
26. HIV-related malignancies: community-based study using linkage of cancer registry and HIV registry data.
Cooksley CD; Hwang LY; Waller DK; Ford CE
Int J STD AIDS; 1999 Dec; 10(12):795-802. PubMed ID: 10639060
[TBL] [Abstract][Full Text] [Related]
27. Non-AIDS defining cancer (NADC) among HIV-infected patients at an oncology tertiary-care center in Mexico.
Cornejo-Juárez P; Cavildo-Jerónimo D; Volkow-Fernández P
AIDS Res Ther; 2018 Oct; 15(1):16. PubMed ID: 30368240
[TBL] [Abstract][Full Text] [Related]
28. [Neoplastic manifestations of HIV infection].
Laatiri MA; Ennabli S
Tunis Med; 2003 Jan; 81(1):5-10. PubMed ID: 12708185
[TBL] [Abstract][Full Text] [Related]
29. Projected Cancer Incidence Rates and Burden of Incident Cancer Cases in HIV-Infected Adults in the United States Through 2030.
Shiels MS; Islam JY; Rosenberg PS; Hall HI; Jacobson E; Engels EA
Ann Intern Med; 2018 Jun; 168(12):866-873. PubMed ID: 29801099
[TBL] [Abstract][Full Text] [Related]
30. [Malignancy cases in HIV-positive patients in Lodz region in years 1992-2010].
Jabłonowska E; Małolepsza E; Strycharz M; Wójcik K
Przegl Epidemiol; 2011; 65(2):339-43. PubMed ID: 21913486
[TBL] [Abstract][Full Text] [Related]
31. Ten-year mortality trends among persons diagnosed with HIV infection in England and Wales in the era of antiretroviral therapy: AIDS remains a silent killer.
Simmons RD; Ciancio BC; Kall MM; Rice BD; Delpech VC
HIV Med; 2013 Nov; 14(10):596-604. PubMed ID: 23672663
[TBL] [Abstract][Full Text] [Related]
32. Immune deficiency and risk for malignancy among persons with AIDS.
Mbulaiteye SM; Biggar RJ; Goedert JJ; Engels EA
J Acquir Immune Defic Syndr; 2003 Apr; 32(5):527-33. PubMed ID: 12679705
[TBL] [Abstract][Full Text] [Related]
33. Risk factors for pediatric human immunodeficiency virus-related malignancy.
Pollock BH; Jenson HB; Leach CT; McClain KL; Hutchison RE; Garzarella L; Joshi VV; Parmley RT; Murphy SB
JAMA; 2003 May; 289(18):2393-9. PubMed ID: 12746363
[TBL] [Abstract][Full Text] [Related]
34. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
Ives NJ; Gazzard BG; Easterbrook PJ
J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320
[TBL] [Abstract][Full Text] [Related]
35. Incidence of human immunodeficiency virus-related and nonrelated malignancies in a large cohort of homosexual men.
Lyter DW; Bryant J; Thackeray R; Rinaldo CR; Kingsley LA
J Clin Oncol; 1995 Oct; 13(10):2540-6. PubMed ID: 7595705
[TBL] [Abstract][Full Text] [Related]
36. Trends and risk of lung cancer among people living with HIV in the USA: a population-based registry linkage study.
Haas CB; Engels EA; Horner MJ; Freedman ND; Luo Q; Gershman S; Qiao B; Pfeiffer RM; Shiels MS
Lancet HIV; 2022 Oct; 9(10):e700-e708. PubMed ID: 36179753
[TBL] [Abstract][Full Text] [Related]
37. Risk of non-AIDS-defining events among HIV-infected patients not yet on antiretroviral therapy.
Zhang S; van Sighem A; Kesselring A; Gras L; Prins JM; Hassink E; Kauffmann R; Richter C; de Wolf F; Reiss P;
HIV Med; 2015 May; 16(5):265-72. PubMed ID: 25604160
[TBL] [Abstract][Full Text] [Related]
38. Factors associated with the occurrence of AIDS-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: Aquitaine Cohort, France.
Bonnet F; Balestre E; Thiébaut R; Morlat P; Pellegrin JL; Neau D; Dabis F;
Clin Infect Dis; 2006 Feb; 42(3):411-7. PubMed ID: 16392091
[TBL] [Abstract][Full Text] [Related]
39. Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era.
El Amari EB; Toutous-Trellu L; Gayet-Ageron A; Baumann M; Cathomas G; Steffen I; Erb P; Mueller NJ; Furrer H; Cavassini M; Vernazza P; Hirsch HH; Bernasconi E; Hirschel B;
AIDS; 2008 May; 22(9):1019-28. PubMed ID: 18520345
[TBL] [Abstract][Full Text] [Related]
40. The changing incidence of four AIDS-related malignancies in a large urban center.
Vilchez RA; Kozinetz CA; Butel JS
AIDS Patient Care STDS; 2001 Aug; 15(8):405-6. PubMed ID: 11522213
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
